文献
J-GLOBAL ID:202002224788561015
整理番号:20A0774460
健常ボランティアにおけるリファンピシンによるOATP1Bの用量依存性阻害:候補バイオマーカーとOATP1Bプローブ薬物の包括的評価【JST・京大機械翻訳】
Dose-Dependent Inhibition of OATP1B by Rifampicin in Healthy Volunteers: Comprehensive Evaluation of Candidate Biomarkers and OATP1B Probe Drugs
著者 (15件):
Mori Daiki
(Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan)
,
Kimoto Emi
(ADME Sciences, Medicine Design, Pfizer Inc., Groton, Connecticut, USA)
,
Rago Brian
(ADME Sciences, Medicine Design, Pfizer Inc., Groton, Connecticut, USA)
,
Kondo Yusuke
(Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan)
,
King-Ahmad Amanda
(ADME Sciences, Medicine Design, Pfizer Inc., Groton, Connecticut, USA)
,
Ramanathan Ragu
(ADME Sciences, Medicine Design, Pfizer Inc., Groton, Connecticut, USA)
,
Wood Linda S.
(Clinical Pharmacogenomics Lab, Early Clinical Development, Pfizer Inc., Groton, Connecticut, USA)
,
Johnson Jillian G.
(Clinical Pharmacogenomics Lab, Early Clinical Development, Pfizer Inc., Groton, Connecticut, USA)
,
Le Vu H.
(Biostatistics, Pfizer Inc., Collegeville, PA, USA)
,
Vourvahis Manoli
(Clinical Pharmacology, Pfizer Inc., New York, New York, USA)
,
David Rodrigues A.
(ADME Sciences, Medicine Design, Pfizer Inc., Groton, Connecticut, USA)
,
Muto Chieko
(Pfizer Inc., Tokyo, Japan)
,
Furihata Kenichi
(P-One Clinic, Keikokai Medical Corp, Tokyo, Japan)
,
Sugiyama Yuichi
(RIKEN Innovation Center, Research Cluster for Innovation, RIKEN, Kanagawa, Japan)
,
Kusuhara Hiroyuki
(Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan)
資料名:
Clinical Pharmacology & Therapeutics
(Clinical Pharmacology & Therapeutics)
巻:
107
号:
4
ページ:
1004-1013
発行年:
2020年
JST資料番号:
A0721B
ISSN:
0009-9236
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)